| Pruritus as a distinctive feature of type 2 inflammation S Garcovich, M Maurelli, P Gisondi, K Peris, G Yosipovitch, G Girolomoni Vaccines 9 (3), 303, 2021 | 87 | 2021 |
| Cutaneous adverse reactions associated with SARS-CoV-2 vaccines F Bellinato, M Maurelli, P Gisondi, G Girolomoni Journal of clinical medicine 10 (22), 5344, 2021 | 79 | 2021 |
| A systematic review of treatments for pityriasis lichenoides F Bellinato, M Maurelli, P Gisondi, G Girolomoni Journal of the European Academy of Dermatology and Venereology 33 (11), 2039 …, 2019 | 64 | 2019 |
| Targeting IL-4 for the treatment of atopic dermatitis A Chiricozzi, M Maurelli, K Peris, G Girolomoni ImmunoTargets and therapy, 151-156, 2020 | 63 | 2020 |
| Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo A Chiricozzi, M Maurelli, N Gori, G Argenziano, C De Simone, ... Journal of the American Academy of Dermatology 83 (1), 39-45, 2020 | 62 | 2020 |
| Advanced glycation end products in the pathogenesis of psoriasis A Papagrigoraki, M Maurelli, M Del Giglio, P Gisondi, G Girolomoni International Journal of Molecular Sciences 18 (11), 2471, 2017 | 49 | 2017 |
| Advanced glycation end products are increased in the skin and blood of patients with severe psoriasis A Papagrigoraki, M Del Giglio, C Cosma, M Maurelli, G Girolomoni, ... Acta Dermato-Venereologica 97 (7), 782-787, 2017 | 44 | 2017 |
| Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review F Bellinato, M Maurelli, P Gisondi, G Girolomoni JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (8), 826-833, 2020 | 29 | 2020 |
| Drug survival of dupilumab compared to cyclosporin in moderate‐to‐severe atopic dermatitis patients G Dal Bello, M Maurelli, D Schena, G Girolomoni, P Gisondi Dermatologic Therapy 33 (6), e13979, 2020 | 26 | 2020 |
| Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study M Maurelli, G Tessari, C Colato, D Schena, G Girolomoni European Journal of Dermatology 28, 44-49, 2018 | 25 | 2018 |
| Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder: A Case Series M Maurelli, C Colato, P Gisondi, G Girolomoni Journal of Cutaneous Medicine and Surgery 21 (6), 502-506, 2017 | 24 | 2017 |
| Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis) L Gargiulo, A Narcisi, L Ibba, A Balato, L Bianchi, P Brianti, D Buononato, ... Frontiers in Medicine 10, 1243843, 2023 | 23 | 2023 |
| Reducing the risk of developing psoriatic arthritis in patients with psoriasis P Gisondi, F Bellinato, M Maurelli, D Geat, A Zabotti, D McGonagle, ... Psoriasis: Targets and Therapy, 213-220, 2022 | 23 | 2022 |
| IL‐17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: a case series with systematic literature review F Bellinato, P Gisondi, M Maurelli, G Girolomoni Dermatologic Therapy 34 (2), e14889, 2021 | 22 | 2021 |
| Community Use of Face Masks against the Spread of COVID-19 CL Bubbico L, Mastrangelo G, Larese-Filon F, Basso P, Rigoli R, Maurelli M ... Int J Environ Res Public Health 18 (6), 3214, 2021 | 21 | 2021 |
| Interferon-beta injection site reactions in patients with multiple sclerosis M Maurelli, R Bergamaschi, A Antonini, MC Fargnoli, E Puma, G Mallucci, ... Journal of dermatological Treatment 29 (8), 831-834, 2018 | 19 | 2018 |
| Overview of atopic dermatitis in different ethnic groups A Chiricozzi, M Maurelli, L Calabrese, K Peris, G Girolomoni Journal of Clinical Medicine 12 (7), 2701, 2023 | 15 | 2023 |
| The combination of dupilumab with other monoclonal antibodies P Gisondi, M Maurelli, A Costanzo, M Esposito, G Girolomoni Dermatology and Therapy 13 (1), 7-12, 2023 | 13 | 2023 |
| Psoriasin (S100A7) is increased in the serum of patients with moderate‐to‐severe psoriasis M Maurelli, P Gisondi, E Danese, M Gelati, A Papagrigoraki, M Del Giglio, ... British Journal of Dermatology 182 (6), 1502-1503, 2020 | 13 | 2020 |
| Kyrle’s disease effectively treated with oral isotretinoin M Maurelli, P Gisondi, G Girolomoni Journal of Dermatological Treatment 29 (6), 630-632, 2018 | 11 | 2018 |
